CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Fernando Rodríguez de Fonseca

OPENALEX: A5014291973↗ORCID: 0000-0002-4516-5795↗

Affiliations

Organizations

Hospital Doctor José Molina Orosaauthorship · ES Universidad Complutense de Madridauthorship · ES

Public evidence

5 connected articles

A Combined GLP-1/PPARa/CB1-Based Therapy to Restore the Central and Peripheral Metabolic Dysregulation Induced by a High-Fructose High-Fat Diet.2025 · Europe PMC The Inflammatory Signals Associated with Psychosis: Impact of Comorbid Drug Abuse2023 · PubMed Central Open Access Plasma Lysophosphatidic Acid Concentrations in Sex Differences and Psychiatric Comorbidity in Patients with Cocaine Use Disorder2023 · PubMed Central Open Access Palmitoleoylethanolamide Is an Efficient Anti-Obesity Endogenous Compound: Comparison with Oleylethanolamide in Diet-Induced Obesity.2021 · Europe PMC A moderate diet restriction during pregnancy alters the levels of endocannabinoids and endocannabinoid-related lipids in the hypothalamus, hippocampus and olfactory bulb of rat offspring in a sex-specific manner.2017 · Europe PMC

Matched by exact identifiers only. Profile data: Corpus/OpenAlex.

Fernando Rodríguez de Fonseca - Medical Cannabis Research Engine